wing vein | P-stage, with Scer\GAL469B
Modest expression of LptdsRNA.Scer\UAS in the wing disc under the control of Scer\GAL4C-765 results in shortened wing veins L2 and L5 at low penetrance.
Compared with wild-type, pupal wing veins appear to be shortened in animals expressing Scer\GAL469B>LptdsRNA.Scer\UAS.
Expression of LptdsRNA.Scer\UAS in the posterior wing compartment under the control of Scer\GAL4en-e16E results in the formation of incomplete veins only in the posterior region of the wing.
Widespread expression of LptdsRNA.Scer\UAS in the presence of Dcr-2Scer\UAS.cDa results in complete lethality, whereas knockdown without Dcr-2Scer\UAS.cDa or knockdown in restricted patterns produces partial lethality and a broad range of developmental defects.
Scer\GAL469B-mediated expression of LptdsRNA.Scer\UAS leads to insignificant changes in the number of circulating hemocytes at the 'clear gut' third instar larval stage.
Scer\GAL4C-765-mediated expression of LptdsRNA.Scer\UAS results in shortened wing veins that can be enhanced by co-expression of Dcr-2Scer\UAS.cDa.
Scer\GAL4ey.PU-mediated expression of LptdsRNA.Scer\UAS results in reduced eye size and loss of head and antennal structures.
LptRNAi.UAS, Scer\GAL4en-e16E has visible phenotype, enhanceable by Dcr-2UAS.cDa, Scer\GAL4en-e16E
LptRNAi.UAS, Scer\GAL4C-765 is an enhancer of visible phenotype of Scer\GAL4C-765, dppRNAi.UAS.cUa
LptRNAi.UAS, Scer\GAL4C-765 is a suppressor | partially of visible phenotype of Scer\GAL4C-765, tkvRNAi.UAS.cUa
LptRNAi.UAS, Scer\GAL4en.PU has wing blade posterior compartment phenotype, enhanceable by Dcr-2UAS.cDa, Scer\GAL4en.PU
LptRNAi.UAS, Scer\GAL4C-765 has wing vein phenotype, enhanceable by trrGD4501, Scer\GAL4C-765
LptRNAi.UAS, Scer\GAL4C-765 has wing vein phenotype, enhanceable by UtxNIG.5640R, Scer\GAL4C-765
LptRNAi.UAS, Scer\GAL4C-765 has wing vein phenotype, non-enhanceable by ash2GD1374, Scer\GAL4C-765
LptRNAi.UAS, Scer\GAL4C-765 has wing vein phenotype, non-enhanceable by wdsGD9379, Scer\GAL4C-765
LptRNAi.UAS, Scer\GAL4C-765 is an enhancer of wing vein L2 phenotype of Scer\GAL4C-765, dppRNAi.UAS.cUa
LptRNAi.UAS, Scer\GAL4C-765 is an enhancer of wing vein L5 phenotype of Scer\GAL4C-765, dppRNAi.UAS.cUa
LptRNAi.UAS, Scer\GAL4C-765 is an enhancer of wing vein phenotype of Scer\GAL4C-765, trrGD4501
LptRNAi.UAS, Scer\GAL4C-765 is a suppressor | partially of wing phenotype of Scer\GAL4C-765, tkvRNAi.UAS.cUa
Simultaneous expression of dppdsRNA.Scer\UAS.cUa and LptdsRNA.Scer\UAS, both under the control of Scer\GAL4C-765, results in further shortening of the wing veins.
Simultaneous expression of tkvdsRNA.Scer\UAS.cUa and LptdsRNA.Scer\UAS under the control of Scer\GAL4C-765 suppresses the tkvdsRNA.Scer\UAS.cUa phenotypes.
Co-expression of Dcr-2Scer\UAS.cDa with LptdsRNA.Scer\UAS under the control of Scer\GAL4en-e16E leads to strong wing blistering.
Scer\GAL4C-765-mediated co-expression of trrGD4501 and LptdsRNA.Scer\UAS results in further shortening of the wing veins compared to expression of either transgene alone.
Co-expression of UtxNIG.5640R strongly enhances the wing vein shortening phenotype of Scer\GAL4C-765, LptdsRNA.Scer\UAS flies.